White Papers are written by organizations to explain a specific business practice, service, product or technology, and provide useful information to readers looking to understand this problem and enhance their job performance. There is no standard subject matter or presentation format but White Papers typically present data supported by facts, figures and statistics to explain the problem and its potential solution. They are generally 2500 words long but can be longer if the topic requires more in-depth discussion, and are written in a narrative voice with no quotes.
White Paper Library
Docuvera White Paper
Digital Transformation in Pharma: Why Structured Content Is the Strategic Foundation: A Strategic Overview for Decision Makers, Economic Buyers, and Regulatory Leaders
Pharmaceutical companies have poured billions into digital transformation. Yet many still struggle to see measurable returns. The reason? Most efforts start in the wrong place. True digital transformation is based around structured content—information created as reusable, metadata-rich components that are: governed at creation for accuracy and compliance; iInteroperable across systems for seamless collaboration; and machine-readable from inception to power automation and AI.
Structured content transforms disconnected data into a strategic asset—accelerating approvals, ensuring global consistency, and maximizing the ROI of your digital investments. Discover how leading pharmaceutical innovators are achieving measurable transformation.
Download
Docuvera White Paper
Utilizing AI-Powered Structured Content Authoring for Global ePI Compliance
Recent pilot programs have demonstrated that electronic product information (ePI) can cut costs while reducing errors and risks to the industry’s companies. As more companies migrate away from word processing and portable document format (PDF) tools, solutions like Docuvera offer significant, cost-effective advantages to ePI implementation over traditional, manual solutions by streamlining and automating global compliance requirements.
Download
Glemser White Paper
The ROI of Automating Translations In-House
The Path to Cost Savings and Compliance with Structured Content AI
Pharmaceutical companies face a costly challenge: managing translations for regulatory content. For years, organizations have relied on external vendors, juggling multiple contracts and navigating redundant processes. AI-powered solutions are transforming how translations are handled, offering faster, more accurate, and more cost-effective alternatives. By automating translations in-house, organizations can optimize operations, improve patient outcomes, and save millions annually. This guide explores the benefits of automated translations, provides actionable insights on implementation, and demonstrates how structured content authoring is uniquely positioned to meet the needs of the pharmaceutical industry.
Download
Docuvera White Paper
AI + Structured Content
A new era of pharmaceutical documentation.
AI and structured content are transforming how organizations create and manage pharmaceutical documentation. Combined, they form a powerful solution that enhances compliance, efficiency, and adaptability in global markets.
In this whitepaper you'll discover how:
Glemser White Paper
Next-Gen Clinical Labeling
Streamlining Authoring and Management Workflows with Structured Content AI
Accurate clinical labels are crucial to the pharmaceutical industry because they directly impact patient safety, regulatory compliance, and clinical trial integrity. The current systems that most companies use typically slow down the overall labeling process, require integration with other systems, and create unnecessary challenges. Thankfully, AI-powered structured content tools and platforms are helping companies transform their internal processes around authoring, collaboration, management, artwork, and submission.
Download
Glemser White Paper
Combining ePI and Structured Content AI for a Patient-Centric Future
Electronic Product Information (ePI) is revolutionizing how patients interact with drug information, offering a more accessible approach to managing product details, improving patient safety, and increasing global interoperability. Delivering ePI using an AI driver takes this innovation a step further, enabling organizations to create, manage, translate, and update content with heightened efficiency and accuracy. This guide explores how the integration of ePI and structured content AI tools fosters a patient-centric future, enhancing patient experiences, sustaining regulatory compliance, and streamlining operations.
Download
Dimensions-Digital Science White Paper
Navigating the AI Landscape: Understanding Trends, Jarconnectn, and Data Readiness
Analyzing publication data from the past decade reveals a remarkable surge in artificial intelligence-related research outputs, reflecting the increasing interest and investment in AI across academia and industry. This white paper looks at the growing importance of AI as evidenced across various metrics (including research publications, research funding, and patents), provides insights to better understand common AI terminology and concepts, and provides an overview of the importance of data readiness for successful AI integration.
Download
Think Company White Paper
Building a Successful Omnichannel Digital Strategy for HCPs
How to plan and implement exceptional experiences that improve HCP engagement, build long-term brand trust, and embrace a smart approach to innovation: To compete in today’s pharmaceutical industry, companies need to deliver best-in-class experiences that exceed the expectations of healthcare providers (HCPs). In this eBook, read about the proven paths to transforming your digital tools and strategy with an omnichannel approach that sets you apart. Whether you’re focusing on digital HCP experiences, content strategy, or AI integration, this eBook provides the insights you need to stay ahead in the evolving pharma landscape.
Download
B. Braun White Paper
Beyond Needlesticks: Multi-Chamber Bags Enhanced with Smart Injection and Infusion Technology
Parenteral nutrition (PN) is a lifesaving intervention utilized across diverse patient populations, spanning all age groups and care environments, ranging from intensive care units to home-based settings. Due to its high complexity, PN is also a high-alert medication with a potential risk of contamination, medication errors, and needlestick injuries (NSIs). Commercial multi-chamber bags (MCBs) are a pivotal advancement in improving the safety of healthcare workers (HCWs) involved in PN delivery, presenting a more efficient approach to PN. Erconnectnomic principles of MCB design play an important role by mitigating the potential risk of errors and NSIs, thereby improving patient and HCW safety and efficacy.
Download
Altmetric White Paper
The Changing Landscape of Journal Performance Measurement
The landscape of journal performance evaluation is changing, thanks to new technologies, platforms, and business models, all of which are transforming how papers gain visibility and impact. Now is an exciting moment to connect beyond the confines of traditional citation-related metrics and to take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption. Download Altmetric's white paper and learn how to utilize the latest impactful metrics for choosing journals effectively.
Download
IQVIA White Paper
eCTD 4.0 Implementation Including Understanding of Regional Differences and Benefits
The creation of the electronic submission process enabled the phasing out of paper-based processes, allowing for more automated and efficient submissions to regulatory bodies. The first version of eCTD 3.0 was finalized in 2003, and eCTD v3.2 has been the default version for more than 10 years since its release in 2008. The initial draft implementation guidelines for eCTD 4.0 were developed in 2015–2016 and intend to improve robustness, flexibility, and long-term stability, and advance the lifecycle management process. After many years of collaboration with regulatory bodies and industry sponsors, eCTD version 4.0 is finally ready for implementation.
Download
ProEd Regulatory, HGC Regulatory Powerhouse White Paper
Embrace the Opportunities in a Changing FDA Advisory Committee Landscape
Over the past four years, we’ve seen seismic shifts in the conduct of FDA Advisory Committee (AdCom) meetings. Changes already in place and those on the horizon are creating new challenges for sponsors. The biggest challenge has been adapting to the virtual format, which then morphed into a hybrid format, and is now transitioning back to in-person meetings. In addition, sponsors have had to deal with tighter timelines for point-counterpoint briefing documents and shared Q&A with the FDA. These challenges also create opportunities for a productive and transparent dialog with clinicians and regulators.
Download
Dimensions White Paper
The Role of Digital Tools in Medical Affairs
How the medical affairs function overcomes critical pain points with digital and AI tools: As digital technology has quickly grown, so has the role of medical affairs, a trend that will continue in the future. Medical affairs professionals are no longer solely responsible for medical accuracy but are now driving overall medical strategy and need as much support as possible to carry out these activities efficiently and effectively. Discover why efficiently assigned resources and new technologies are pivotal to the success of medical affairs teams.
Download
Glemser White Paper
ePI & the Future of Pharma Labels: Reinventing Content Authoring to Improve Patient Outcomes
This guide delves into the profound impact of electronic Product Information (ePI) on the pharmaceutical industry and healthcare ecosystem, exploring how it not only revolutionizes content authoring but also sets the stage for a future where patients are empowered with accessible, personalized, comprehensible information about their health and medications. It also focuses on how AI-powered structured content authoring platforms help equip companies with the tools to streamline and enhance their content-authoring and -management processes, getting them ready for an ePI world.
Download
Glemser White Paper
AI & Global Labeling: How Next-Gen Tools Are Streamlining Structured Component Authoring Effectively and Compliantly
Outside of the physical drug product itself, global labeling plays the most fundamental role in helping pharmaceutical companies deliver safe and effective therapies to the population. But the process behind global labeling—the authoring, editing, collaborating, translating, and publishing of drug labels—is both incredibly complex and time-consuming. This guide explores how AI-powered tools are helping teams simplify and accelerate their in-house authoring workflows, without sacrificing compliance. It also explains how, by using such tools, companies can transform not just the way they work but also the entire “last mile” of the drug development lifecycle.
Download